- ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-blind, Active Comparator-controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older
This study is testing a new vaccine (V116) for pneumonia in adults aged 50 and over. We want to see how safe it is, how well people tolerate it, and if it helps their immune system fight off pneumonia germs compared to an existing vaccine.
Spain · Germany - ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Children and Adolescents With Increased Risk of Pneumococcal Disease.
This study is testing a new vaccine (V116) to see how well it works and if it's safe for children and teens who are more likely to get sick from certain bacteria called pneumococcus. It compares the new vaccine to existing ones.
Sweden · Poland · France - recruitingPHASE4
Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15
This study tests a new vaccine, PCV15, for pneumococcal disease. Researchers will see if it stops people carrying the bacteria in their nose, which can prevent serious illness. Volunteers will get the real vaccine or a dummy, then have a small amount of bacteria put in their nose.
United Kingdom